Treatment of pseudoglandular stage fetal lungs in vitro with the pan-retinoic acid receptor (pan-RAR) antagonist, BMS493, reduces retinoic acid receptor beta (Rarb) gene expression within the proximal bronchial tubules and increases explant bud formation. Treatment with retinoic acid (RA) increases Rarb expression and reduces explant bud formation through a signaling mechanism involving RARb. Together these data suggest that RA through RARb provides morphogenetic stabilizing activity to the proximal tubules during lung branching morphogenesis. Here we further investigate RA-mediated morphogenetic stabilization of the proximal respiratory tubules during fetal lung development. We demonstrate that Rarb isoform transcripts are the only known Rar transcripts to specifically localize to the proximal tubules and that RAREhsp68lacZ reporter transgene activity reveals endogenous RA signaling activity within these same proximal tubules. Furthermore, the expression patterns of the RA-producing enzyme retinaldehyde dehydrogenase 1 (Raldh1), as well as of transforming growth factor-3b (Tgfb3), Foxa2, and the cystic fibrosis transmembrane conductance regulator (Cftr) within the proximal tubules are all altered by the application of either RA or BMS493 in vitro. We therefore discuss an interbud/proximal tubule signaling niche involving feedback between Rarb expression and Raldh1-mediated synthesis of RA. We suggest that this feedback favors interbud morphogenetic stability by increasing expression of morphoregulatory molecules such as TGFb3 and Foxa2, thus promoting bronchial tubule formation rather than continual budding and branching. The relationship between this RAR signaling center and the previously described distal bud signaling center is also addressed. q
Introduction
Vitamin A (retinol) exerts profound effects upon a vast number of development process via signaling through heterodimerization complexes comprising retinoic acid receptors and retinoid X receptors (RARa, b and g and RXRa, b and g), transcription factors which belong to the nuclear receptor superfamily (see Kastner et al., 1995; Chambon, 1996; Kastner et al., 1997; Mascrez et al., 1998) . Transcriptional activation by RAR/RXR heterodimers is generally accomplished by binding of either vitamin A metabolite, all-trans or 9-cis retinoic acid (at-and 9c-RA, respectively), to the RAR partner. Signaling through the RXR partner in this configuration is subordinate, being silenced in the absence of RAR ligand binding. When RAR ligand is limiting, however, signal transduction for attenuation of transcriptional activity via RXR may be achieved in a 9c-RA specific fashion (for reviews see Mangelsdorf and Evans, 1995; Chambon, 1996; Vivat et al., 1997) .
The importance of vitamin A as a major determinant of early vertebrate lung development was established with the finding that fetuses from pregnant female rats fed a vitamin A deficient diet displayed either agenesis of the left lung or rudimentary lung buds (Warkany et al., 1948) . In the rat, this effect was attributed to a developmental mechanism associated with laryngotracheal groove formation, as the lung phenotype could be rescued by the reintroduction of vitamin A to the maternal diet at embryonic day 10 (E10) or E11 but not afterwards, when the primitive lung anlagen had formed (Wilson et al., 1953) . Compound genetic mutations of certain Rars and/or Rxrs in mice produced a similar lung phenotype, thus demonstrating the importance of biological activation of vitamin A and signaling via RARa/RXRa and RARb/RXRa heterodimers for early embryonic lung development (see Mendelsohn et al., 1994; Mascrez et al., 1998) . Further supporting these findings, treatment of E8.0 mouse embryos in vitro with the pan-RAR antagonist BMS493, 1.5 days prior to the first morphological appearance of the mouse lung primordia, induced embryonic lung hypoplasia (Mollard et al., 2000a) .
During the subsequent pseudoglandular stage of lung development (see Ten Have-Opbroek, 1991) , signaling via RA and its nuclear receptors once again has profound influences upon lung morphogenesis, stabilizing established bronchial tubules and inhibiting explant budding. For example, blocking RAR signaling by administering BMS493 to E11.75 and E12.5 lung buds in vitro increases branching activity, whereas administration of RA reverses this stimulatory effect and decreases branching (Mollard et al., 2000a) . The expression of both Fgf10 and Shh are downregulated within the distal buds following exogenous RA administration, and have been thus postulated to interpret the inhibitory effect of RA signaling upon branching morphogenesis (see Malpel et al., 2000 and references therein) .
We previously showed that Rarb transcripts are specifically expressed within the proximal airways of the pseudoglandular lung and are downregulated concomitant to the increase in branching activity following pan-RAR antagonism (Mollard et al., 2000a) . Furthermore, lungs from Rarb-null embryos are less sensitive to the suppressive effects of RA administration upon branching morphogenesis in vitro and Rarb-null neonates demonstrate a greater alveolar number (Mollard et al., 2000a; Massaro et al., 2000) . Together these data strongly suggest that endogenous RA signaling via RARb acts to stabilize tubule formation by restricting the number of buds being formed during branching morphogenesis. Here we further examine the role of RA signaling pathways during pseudoglandular lung development by analyzing the proximal bronchial tubule regions, morphogenetically stable areas associated with Rarb expression (see Hilfer et al., 1985; Dollé et al., 1990) . We previously reported the localization of Rarg1 isoforms specifically within the distal bud epithelium and tracheal mesenchyme (Mollard et al., 2000a ). Here we demonstrate that only the Rarb1/3 and Rarb2/4 isoform transcripts, and not Rara1, Rara2 or Rarg2 transcripts, show site-specific expression within the proximal tubules. RAREhsp68lacZ transgene expression also localizes to the proximal tubules and thus provides evidence that endogenous RA synthesis and transcriptional activity are present within these areas. Furthermore, changes in the expression of Raldh1, Tgfb3, Foxa2 and Cftr within the proximal tubules are altered following administration of either RA or BMS493.
Similarly, BMS493 alters the expression of Bmp4, Fgf10 and Shh within the distal buds. The functional significance of RA synthesis and RA-regulated expression of Rarb, Raldh1, Tgfb3 and Foxa2 upon proximal tubule formation during pseudoglandular lung development and their relationship to the distal/apical signaling center are therefore discussed (see also Weaver et al., 1999; Malpel et al., 2000) .
Results

RAR isoform expression in the E13.5 lung
Four individual isoforms are generated by differential promoter usage and alternative splicing from the Rarb gene (see Mollard et al., 2000b , and references therein). Rarb1 and Rarb3 mRNAs are transcribed from the same distal promoter and Rarb2 and Rarb4 mRNAs are transcribed from the same proximal RA-responsive promoter (Zelent et al., 1991) . At E13.5, Rarb isoforms are expressed specifically within the lung proximal conducting airway epithelium and the immediately adjacent mesenchyme, whereas Rarg1 is expressed within the distal bud epithelium and tracheal mesenchyme (see Dollé et al., 1990; Ghyselinck et al., 1998; Mollard et al., 2000b) . No data have been reported on Rara1, Rara2 or Rarg2 transcript localization during pseudoglandular lung development. To determine whether any of these latter RAR isoforms display expression patterns specifically within the proximal tubules during branching morphogenesis at E13.5, we re-examined the hybridization of probes discerning the common Rarb1/3 and Rarb2/4 transcripts, but also probes that discern the specific expression of Rara1, Rara2 and Rarg2 transcripts. As previously described, Rarb1/3 and Rarb2/4 transcripts localized to lobar bronchial and bronchial epithelium and mesenchyme (Fig. 1) . On the other hand, ubiquitous expression within the E13.5 lung was observed following hybridization with Rara1, Rara2 and Rarg2 isoformspecific probes (Fig. 1) . Thus, Rara1, Rara2 and Rarg2 transcripts overlap with Rarb expression in the proximal tubules, but are not restricted to the proximal tubules.
Proximal RAREhsp68lacZ transgene expression in the pseudoglandular lung
The RAREhsp68lacZ reporter transgenic line harbors a tetrameric repeat of the Rarb2 retinoic acid response element (RARE) linked to the hsp68 minimal promoter and has been widely used as a RA-reporter transgene (see Rossant et al., 1991; Sakai et al., 2001) . RAREhsp68lacZ transgenic lungs display b-galactosidase activity within the epithelium up to day 11.5, after which time activity becomes largely undetectable (see Malpel et al., 2000; Niederreither et al., 2002a) . By E14.5, RAREhsp68lacZ expression was reported to be limited to the pleural mesothelium and lobular septa (Malpel et al., 2000) . Reporter transgene expression thus may not accord with a role for RA transcriptional activation or repression within the pseudoglandular tubules. Pan-RAR antagonism, however, stimulates lung branching of E11.75 and E12.5 lungs after 48 h of culture and inhibits Rarb expression within the lobar bronchi and bronchi. We thus chose to re-examine the expression pattern of the RAREhsp68lacZ reporter transgene in association with pseudoglandular stage bronchi (E13.5 to E14.5) under more sensitive staining conditions. As previously reported, E13.5 and E14.5 RAREhsp68lacZ transgenic lungs display b-galactosidase activity within mesothelial cells of the pleura ( Fig. 2A and data not shown; Malpel et al., 2000) . Using a double staining technique incorporating the vasculature marker PECAM-1 (CD31), bgalactosidase activity was also detected throughout the proximal portions of the primordial lobar bronchial and bronchial epithelium, in a pattern strongly overlapping Rarb expression at this time (see Fig. 2A , B and compare with expression pattern of Rarb isoforms in Fig. 1 ) b-galactosidase activity in the adjacent primitive mesenchyme was not detectable using this method. Other areas of activity included: the vascular walls, elements of the lymphatic network and the occasional distal bud involuting towards the primary bronchi. Although speculative, such localization in the involuting buds may correspond to an inhibitory signal preventing further growth in accordance with spatial restrictions and the control of directional bud outgrowth in this region. RAREhsp68lacZ transgene activity was not detected within the peripheral distal bud epithelium and mesenchyme. These data thus accord with endogenous RA transcriptional regulation taking place within the lobar bronchial and bronchial epithelium throughout the pseudoglandular phase of lung development.
2.3. Expression of the gene encoding the RA synthesizing enzyme RALDH1 within the proximal tubules is regulated by RA and BMS493
Rarb is expressed specifically within proximal tubules at E13.5 and the inhibitory effect of RA signaling upon branching morphogenesis is less pronounced in lungs explanted from Rarb-null fetuses than their wild-type littermates (Mollard et al., 2000a) . Furthermore, RAREhsp68lacZ transgenic lungs demonstrate endogenous RA signaling within the proximal tubules. Thus, endogenous RA signaling appears to act through RARb to inhibit branching, or rather stabilize tubule formation. RALDH1 (also known as ALDH1A1) catalyses the oxidation of retinaldehyde to RA and is expressed at relatively high levels within these same proximal bronchi from E12.5 to E14.5 ( Fig. 3A -C ; Niederreither et al., 2002a,b) . Expression in the distal bud epithelium is relatively reduced at this time (Fig. 3A, B) . As previously reported, Raldh2 expression is restricted to the pleural mesothelium ( Fig. 3D ; Malpel et al., 2000; Niederreither et al., 2002b) . Raldh1 is therefore a strong candidate for the production of endogenous RA and thus mediator of RARb signaling and morphogenetic stabilization within the proximal bronchi. We thus chose to further examine the proximal bronchial RA signaling niche to determine whether changes in the The top left hand panel shows a bright field view of one of the dark field images depicted in the remainder of the figure, which show the in situ hybridization signal as white grains. The Rarb1/3 and Rarb2/4 isoformspecific probes hybridize specifically to the proximal bronchial tubes. In contrast, ubiquitous hybridization of the Rara1, Rara2 and Rarg2 specific isoform probes is observed. br, bronchial tubes; db, distal bud; lob, lobar bronchus. Scale bar ¼ 250 mm. expression of an enzyme that regulates RA synthesis correspond to changes in morphogenetic activity.
Previously, the inhibitory effect of 10 26 M at-RA upon lung branching morphogenesis was shown to be reduced by the concomitant administration of 10 26 M BMS493 (Mollard et al., 2000a) . It is thus unlikely that either of these exogenously added retinoids exert significant non-specific teratogenic effects upon the culture system at these concentrations. In all of the following experiments, lung explants were thus grown in the presence of BMS493 and at-RA at a final concentration of 10 26 M for 36 h prior to gene expression analysis. With respect to Raldh1 expression, blocking RAR signaling by adding BMS493 to E12.5 lung cultures increased Raldh1 expression specifically within the lobar bronchial and bronchial epithelium, whereas the addition of RA to this culture system reduced Raldh1 expression (Fig. 3E ). These changes in Raldh1 expression levels, which were confirmed by RNAse protection assays (Fig. 3F) , are unlikely to be due to alterations in the epithelium to mesenchyme ratio as previous studies demonstrated that treatment with either retinoid did not change relative levels of the mesenchymal marker vimentin (see Mollard et al., 2000a) . RALDH1 and RA thus appear to participate in a feedback loop for the regulation of specific levels of RA synthesis within the proximal tubules.
Pan-RAR antagonism alters the expression of Tgfb3, Foxa2 and Cftr in proximal tubules
During branching morphogenesis of the lung, Tgfb3 is expressed in a dynamic pattern being found within the pleural mesothelium, the mesenchyme surrounding the lobar bronchi and within the epithelium of the more distal bronchial tubules (Pelton et al., 1990; Millan et al., 1991; Bragg et al., 2001 ). The bronchial expression pattern therefore overlaps that of Rarb and Raldh1 and suggests that Tgfb3 may be a target of RA signaling. Furthermore, the addition of TGFb3 to lung in vitro culture systems inhibits branching morphogenesis demonstrating that like RA, TGFb3 is an inhibitor of lung branching (Bragg et al., 2001 and references therein). This inhibitory effect of TGFb3 upon lung branching is believed to involve the coaction of extracellular and/or mesenchymal factors, as intralumenal injection of TGFb3 specifically to the luminal aspect of the epithelium results in no detectable inhibition of branching activity (Bragg et al., 2001 ). Whole-mount in situ hybridization of E12.5 control explants cultured for 36 h demonstrated Tgfb3 transcript localization specifically within lobar bronchial mesenchyme, bronchial epithelium and pleura, while no expression was detected within the terminal distal bud epithelium (Fig. 4A , lbm, p, db). Relative to controls, expression of Tgfb3 associated with the bronchi, pleura and mesenchyme decreased following Hybridization of the Raldh1 probe is observed specifically throughout the lobar bronchial and bronchial epithelium, whereas only background levels are observed in the distal bud epithelium and throughout the mesenchyme (A -C). Hybridization of the Raldh2 probe is observed specifically within the pleura (D). Treatment of E12.5 lung explants with BMS493 increases Raldh1 expression throughout the proximal bronchi whereas treatment with at-RA decreases Raldh1 expression (E,F). db, distal bud; lob, lobar bronchi; br, bronchi; p, pleura; e, epithelium; m, mesenchyme. Scale bar ¼ 250 mm. BMS493 treatment and increased following RA treatment (Fig. 4A, B) . Furthermore, although four days of culture reproducibly reveals the stimulatory effect of BMS493 and the inhibitory effect of RA upon bud formation (see Mollard et al., 2000a) , such effects can also be observed here after 36 h of culture.
Expression of Foxa2, formerly Hnf3b, a regulator of epithelial differentiation and inhibitor of lung branching morphogenesis, was next examined (see Zhou et al., 1997) . In accordance with previously described data, Foxa2 expression within the E12.5 lung cultured for 36 h was relatively high within the lobar bronchial and bronchial epithelium, showing a gradual diminution towards the distal bud areas ( Fig. 5 ; Zhou et al., 1996) . Foxa2 expression within the proximal bronchi was reduced by treatment with either BMS493 or at-RA (Fig. 5A, B) . Foxa2 transfection of embryonic stem cells positively regulates Cftr expression and CFTR displays a proximo-distal gradient within the respiratory epithelium during fetal development (McCray et al., 1992; Tizzano et al., 1993; Levinson-Dushnik and Benvenisty, 1997) . After 36 h of culture, Cftr expression was detected only within the lobar bronchi of the developing lung (Fig. 5A) . Treatment with BMS493 upregulated Cftr expression within the lobar bronchial and bronchial epithelium, whereas treatment with RA reduced Cftr expression within the lobar bronchi (Fig. 5A, B) . Because Foxa2 and Cftr are expressed within the centrally located tubules of control lung explants and treatment with BMS493 and RA expands and reduces the size of the explants, respectively, we once again investigated alterations in expression levels by RNAse protection assays. These assays confirmed that changes in expression levels as observed by in situ hybridization are not attributable to changes in antibody and probe accessibility to the targets (Fig. 5B) .
Changes in expression of the proximal markers Raldh1, Tgfb3, Foxa2 and Cftr following both BMS493 and RA administration, therefore, demonstrate that effectors of proximal tubule epithelial morphogenesis and differentiation are intimately linked to, but not all necessarily direct targets of, the RA signaling mediated regulation of branching morphogenesis. Together, these data suggest that RA, RARb and RALDH1 participate in a retinaldehyde processing niche affecting transcription of proximal markers relevant to tubule formation and differentiation during lung morphogenesis. Furthermore, the overlapping expression patterns of Raldh2 and Tgfb3 within the mesothelial pleura suggest an additional RA signaling mechanism linking Raldh2 mediated RA synthesis with the regulation of Tgfb3 expression during development of the pleura.
Pan-RAR antagonism alters expression of Bmp4, Fgf10 and Shh within the distal buds
Previously BMP4, FGF10 and SHH have been implicated as interpreters of RA signaling within the budding tips of the branching lung. Bmp4 is expressed specifically within the distal epithelial tips where it is postulated to maintain the epithelium in a distal character (Weaver et al., 1999) . RA reduces Bmp4 expression and thus accords with a role in inhibiting budding by proximalizing the distal epithelium (Malpel et al., 2000) . Fgf10 is expressed in the distal mesenchyme adjacent to the budding epithelial tips and is believed to act as a chemoattractant for new bud formation (Park et al., 1998) . The addition of RA to E11.5 lung explant cultures reduces Fgf10 expression and thus accords with a role in the reduced budding observed following RA treatment (Bellusci et al., 1997a; Malpel et al., 2000) . Shh is similarly a potent effector of lung branching morphogenesis; it is expressed thoughout the epithelium with highest levels in the distal buds and the addition of RA to rat and mouse lung explants results in an increase in Shh expression (Cardoso et al., 1996; Bellusci et al., 1997a,b; Pepicelli et al., 1998; Litingtung et al., 1998 ). An apical signaling center comprising BMP4, FGF10 and SHH activity regulated by RA, has thus been postulated to control proximal -distal differentiation and growth of the fetal lung during branching morphogenesis (see Weaver et al., 1999; Malpel et al., 2000) . To confirm that endogenous RA signaling plays a role regulating this apical signaling center, we tested the effect of blocking RAR signaling upon these distal markers by treating lung explants with BMS493.
BMS493 increased expression of Bmp4 specifically within the distal budding tips and Fgf10 throughout the lung mesenchyme (Fig. 6A, A 0 , B, B 0 , D, D 0 , E, E 0 ). In our E12.5 lung bud system, 10 26 M RA reduced Bmp4 expression yet had no effect upon Fgf10 expression (Fig. 6A, A 0 , C, C 0 , D, D 0 , F, F 0 ). BMS493 decreased Shh expression in the distal tips and proximal bronchi, whereas RA increased expression throughout the epithelium (Fig. 6G -I 0 ). Thus blocking endogenous RA signaling with the pan-RAR antagonist affects expression of these distal morphoregulatory molecules of the apical signaling center.
Discussion
Bronchial tubules are formed by a ramification process initiated during the pseudoglandular stage of lung development (see Ten Have-Opbroek, 1981) . The establishment of this proximal conducting portion of the lung occurs according to a process known as branching morphogenesis and depends upon epithelial/mesenchymal interactions that specify points of morphogenetic inactivity or stabilization (Hilfer et al., 1985) . Although several molecular mechanisms governing formation of the morphogenetically active distal budding structures (the presumptive respiratory portion of the lung) have been delineated, those governing formation of the morphogenetically inactive or stable conducting tubules remain poorly understood. By altering branching morphogenesis in vitro with both RA and the pan-RAR antagonist BMS493, our results identify several candidates for the mediation of bronchial tubule formation and furthermore delineate two non-overlapping RAR response centers of morphogenetic regulation: the proximal conducting and distal budding elements. The RAR responsive proximal element can be defined by a niche regulating Raldh1, Tgfb3, Foxa2 and Cftr expression and appears to exert cues required for stabilization of the tubules to prevent further budding. The distal element can be defined by a niche regulating Bmp4, Fgf10 and Shh expression and, as previously reported, is intimately associated with the promotion of bud formation and outgrowth (see Bellusci et al., 1997a; Malpel et al., 2000 , and references therein).
RA signaling within the proximal tubules
In agreement with the proposal for a proximal localization of endogenous RA signaling, activity of the RAREhsp68lacZ reporter transgene was detected at E14.5 within the proximal bronchial epithelium, in a pattern overlapping that observed for Raldh1. The localization of Rara1, Rara2, Rarb1, Rarb2 and Rarg2 expression within these proximal regions, the activity of the RARE transgene, the expression of an enzyme linked to the production of RA, and the stimulatory effects of BMS493 upon branching morphogenesis together suggest that RA is being produced, transactivating gene expression through its nuclear receptors and stabilizing tubule formation. The specific localization of the Rarb isoforms to the proximal tubules is particularly noteworthy. Indeed, Rarb isoform expression is highly responsive to both RA and BMS493 treatments, and Rarb-null lungs have a reduced sensitivity to exogenous RA treatment (Mollard et al., 2000a) . Furthermore, RA and TGFb3 are both inhibitors of pseudoglandular bud formation when applied to lung culture systems and the expression of Rarb and Tgfb3 are reduced in the proximal tubules at a time of BMS493-stimulated branching activity (see Cardoso et al., 1995; Mollard et al., 2000a; Massaro et al., 2000; Bragg et al., 2001) . It therefore appears possible that RA via RARb signaling exerts an inhibitory effect upon lung branching morphogenesis, at least in part through its regulation of Tgfb3 expression.
Although supported by in vitro studies, such a hypothesis is not currently supported by knowledge gained from the Tgfb3-null mouse model. Newborn lung lobation and size are not obviously different between Tgfb3-null mutants and wild-type littermates, yet at E18.5 the mutant lungs Fig. 6 . Bmp4, Fgf10 and Shh expression in the pseudoglandular lung following retinoid treatment. In control explants cultured for 36 h, Bmp4 expression was localized to the distal most epithelium of the distal buds (A). At this time, Fgf10 expression localized to the distal bud mesenchyme and the mesenchyme surrounding the more proximal tubules and Shh expression localized to the distal bud epithelium, with some hybridization also evident in the epithelium of the proximal tubules (D,G). BMS493 treatment increased Bmp4 expression specifically within the distal bud epithelium and globally increased expression of Fgf10 throughout the mesenchyme (B,E). BMS493 decreased Shh expression within the distal buds and to a lesser extent within the proximal tubules (H). RA reduced Bmp4 expression, had no apparent effect upon Fgf10 expression and increased Shh expression within the distal buds and proximal tubules (C,F,I). db, distal bud epithelium; dbm, distal bud mesenchyme, pt, proximal tubules. Scale bar ¼ 250 mm.
demonstrate a hypoplastic phenotype attributable to a delayed maturation during the late canalicular and terminal sac stages of lung development (Kaartinen et al., 1995; Shi et al., 1999) . It has thus been suggested that TGFb3 plays no significant effect upon branching morphogenesis (see Shi et al., 1999) . However, TGFb3 potentially represents just one molecule of many participating in the stabilization of the newly forming proximal conducting tubules and, as in the case of Rarb-null mutants, subtle effects of the knockout upon the respiratory system may not be observed unless compound mutations or more sensitive stereological studies are undertaken (see Mendelsohn et al., 1994; Mascrez et al., 1998; Massaro et al., 2000) . In this respect, the involvement of increased Tgfb3 expression in branching inhibition following RA treatment is consistent with the inhibition of branching activity observed following the addition of exogenous Tgfb3 to lung culture systems. Accordingly, it is possible that reduced Tgfb3 expression following RAR antagonism would participate in the release of proximal tubule forming centers from morphogenetic restraint, leading to a subsequent increased branching activity. Such a hypothesis is in line with the proposed model that a decrease in Tgfb3 expression could promote branching (see Bragg et al., 2001) .
With regard to other proximal bronchial markers, the sensitivity of Raldh1 expression to changes in RAR signaling activity suggests the local RA concentration within the proximal region can be controlled by a feedback mechanism through the RARs and RALDH1. In this manner, a fine tuning of the site-specific delivery of RA signal transduction to the proximal tubules would be provided. With respect to Foxa2 expression, transgenic upregulation of Foxa2 throughout the fetal respiratory epithelium under the control of the surfactant protein C promoter results in arrested distal epithelial differentiation and an inhibition of branching (Zhou et al., 1997) . The reduced expression of Foxa2 following BMS493 treatment at a time of increased branching activity would thus accord with Foxa2 being a repressor of lung branching. The similar reduction in expression following RA treatment, however, suggests that Foxa2 expression can be regulated by both RA-direct and -indirect mechanisms. Thus, although Foxa2 expression inhibits lung branching, Foxa2 is expressed in areas of morphogenetic stability and its expression can be regulated by blocking RAR signaling, applying exogenous RA would appear to also activate a repressor of Foxa2 expression. Such a complex RA-mediated Foxa2 regulatory mechanism may be expected given the crucial role of Foxa2 for development of both the foregut and midgut endoderm (Dufort et al., 1998) .
The effect of RA signaling upon Cftr expression in respiratory epithelia has not been well defined (see Ikeda et al., 1994; Jun et al., 2001) . Consequently, we also chose to examine Cftr responsiveness to RA and BMS493 because it is specifically expressed within the developing bronchial epithelium and because it is regulated by Foxa2 in mouse ES cells (McCray et al., 1992; Tizzano et al., 1993; Levinson-Dushnik and Benvenisty, 1997) . Inhibition of RAR signaling by the pan-RAR antagonist resulted in increased Cftr expression throughout the proximal and lobar bronchi, and even if an indirect affect, provides further evidence that RA signaling is active within these tubules. Cftr over-expression driven by either the surfactant protein C or the 10-kDa Clara cell promoter, however, had no apparent effect upon somatic lung development, thus suggesting that increased CFTR alone cannot alter lung morphogenesis (Whitsett et al., 1992) .
RA signaling through the distal center
Bmp4, Fgf10 and Shh expression are all affected by a block in RAR signaling at a time of increased branching morphogenesis. Our data thus accord with a role of the apical signaling center in the interpretation of endogenous RA signaling required for bud formation and directional outgrowth (see Malpel et al., 2000) . The increased expression of Bmp4 only within the distal buds (and not throughout the bronchial epithelium) following BMS493 treatment, however, demonstrates that blocking RAR signaling does not affect a BMP4-dependent alteration of proximo-distal patterning. Furthermore, FGF10 is proposed to act as a chemoattractant for newly formed buds during branching morphogenesis (Park et al., 1998) . Following BMS493 treatment, however, Fgf10 expression was increased ubiquitously throughout the lung instead of in precise localizations relevant to the directional guidance of bud outgrowth. Thus, the increase in budding by blocking RAR signaling is not exerted solely through changes in Fgf10 expression. To this end, it would be interesting to examine the effect of BMS493 upon expression of members of the Sprouty gene family; these factors are expressed within the distal regions, regulate FGF signaling and thus represent candidates for the exertion of site-specific directionality to the ubiquitous FGF10 signal (see de Maximy et al., 1999; Mailleux et al., 2001 ). Although it is unclear why Fgf10 expression is refractory to RA in our system, Northern blot analysis and semiquantitative PCR of E11.5 lung explants treated with RA for either 24 h or 4 days have demonstrated reductions in Fgf10 expression (Bellusci et al., 1997a; Malpel et al., 2000) . The reason for this discrepancy is unknown, and stage-specific effects may play a role.
The changes in Shh expression following BMS493 and RA treatment accord with the proposed role of SHH as a negative regulator of Fgf10 expression in the distal buds (Bellusci et al., 1997a) . Whether the reduction in Shh expression is sufficient to explain the global increase in Fgf10 expression throughout the lung requires further examination. Thus, while it is clear that blocking endogenous RAR signaling exerts profound effects upon markers of the apical signaling center, how endogenous RAR signaling coordinates these molecules to regulate directional bud outgrowth requires further study.
Conclusion
This study provides evidence of two relatively independent functions of locally synthesized RA for branching morphogenesis of the lung. One function appears to require relatively high levels of RA and stabilizes proximal tubule formation through an RA/RARb feedback loop involving Raldh1, Tgfb3 and Foxa2 expression. The second function requires relatively low levels of RA, most likely produced by RALDH2 in the pleural mesothelium (see also Malpel et al., 2000) , to mediate activity within the apical signaling center and regulate the expression of genes implicit to distal bud outgrowth such as Fgf10 and Shh.
Experimental procedures
Mice and lung culture
Embryos from CD1 £ CD1 natural matings were collected in phosphate-buffered saline (PBS) and the lungs excised either for culture in BGJB medium (Fitton-Jackson modified, Gibco BRL), 5% de-lipidated fetal calf serum (FCS, Gibco BRL) and 180 mg/ml vitamin C (Sigma) on Millipore filters (Gibco BRL) at 378C in the presence of 5% CO 2 or processed for radioactive in situ hybridization. The morning of appearance of seminal plug was designated as E0.5. E12.5 lung explants were cultured in the presence of 10 26 M at-RA or BMS493 for 24 h, and a fresh aliquot of retinoid-treated media was added for a further 12 h, as previously described (Mollard et al., 2000a) .
b-galactosidase activity and anti-PECAM-1 antibody immunohistochemistry
E13.5 and E14.5 lungs were dissected in cold PBS, washed twice and then fixed immediately for 15 min at room temperature in 0.2% glutaraldehyde, 5 mM EDTA and 2 mM MgCl2 in PBS. Following three 15 min washes in 1.5 mM MgCl2, 0.01%sodium deoxycholate and 0.02%NP40 in PBS at room temperature, overnight staining at 378C in 1 mg/ml X-gal, 5 mM K-ferrocyanide and 5 mM K-ferricyanide in PBS, two subsequent washes in PBST (PBS with 0.01% Triton 100) and a 30 min preblock in 10% fetal calf serum in PBST, lungs were incubated overnight at 48C with anti-PECAM-1 antibody (1/200, Pharmingen, MEC13.3) in 10% FBS with PBST. Lungs were then washed six times for 30 min each in PBST. Secondary antibody coupled to peroxidase (Vector) was incubated overnight at 48C. After six washes in PBST, staining was achieved using the Vectastain DAB kit (Vector). Lungs were postfixed in 4% paraformaldehyde and processed for paraffin sections.
Molecular analysis
Radioactive in situ hybridization, whole-mount in situ hybridization, riboprobe synthesis and RNAse protection were performed as previously described (Chirgwin et al., 1979; Décimo et al., 1995; Mollard and Dziadek, 1997; Niederreither and Dollé 1998; Mollard et al., 2000a) . For radioactive in situ hybridization, at least three individual animals were analyzed per probe. For whole-mount in situ analysis, at least ten lung explants were processed per group and at least three individual experiments per cRNA probe were performed. For RNAse protections, RNA was collected from four individual experiments and performed with 2 mg RNA per reaction. Exposure times varied between 4 and 24 h. The isoform-specific Rara, Rarb and Rarg, and the Raldh1 and Raldh2 riboprobes have been described previously (Mollard et al., 2000b; Niederreither et al., 2002b) . Full-length Raldh1, Tgf3, Foxa2 and Bmp4 cDNAs, a 584 bp Fgf10 PCR fragment (see Bellusci et al., 1997a) , a 600 bp EcoR1 Shh cDNA from a E8.5 mouse library and a 220 bp HindIII digestion of a 604 bp Cftr PCR fragment subcloned into pGEMTeasy were used as templates for whole-mount in situ hybridization. The Cftr fragment was subcloned by PCR from adult mouse lung cDNA with the following primer pairs: forward primer 5 0 -CGCAGGTTCTCAGTAGACGATTCC-3 0 ; reverse primer 5 0 -CCTCAACCAGAAAAACCAGTACGC -3 0 (NCBI accession number: NM_021050). For RNAse protections, the 220 bp HindIII Cftr restriction, a 300 bp AvaII Raldh1 restriction, a 465 bp NcoI Tgfb3 restriction and a 340 bp AccI Foxa2 restriction of the above cDNAs were used as templates for riboprobe synthesis.
